Comparison of estrogen and genistein in their antigenotoxic effects, apoptosis and signal transduction protein expression patterns

BioFactors

Volumn 21, Issue 1-4, 2004, Pages 379-382

  Ock, Park Jin ^a  

^a Hannam University   (South Korea)

Author keywords

Antiproliferative effects; Apoptosis; Genotoxicity; Isoflavones (genistein)

Indexed keywords

CYCLIN B1; ESTROGEN; GENISTEIN; ISOFLAVONE; PLASMID DNA; ANTIMUTAGENIC AGENT; DNA; ESTRADIOL; ISOFLAVONE DERIVATIVE;

APOPTOSIS; CANCER PREVENTION; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CORRELATION ANALYSIS; DNA STRAND BREAKAGE; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ARTICLE; BREAST TUMOR; DNA DAMAGE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; PLASMID; TUMOR CELL LINE;

ANTIMUTAGENIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA DAMAGE; DNA, NEOPLASM; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; ISOFLAVONES; PLASMIDS; SIGNAL TRANSDUCTION;

EID: 16444382741     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.552210173     Document Type: Conference Paper

References (11)

1. A.M. Brzozowski, C.W. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, O. Engstrom, L. Ohman, G.L. Greene, J. Gustafsson and M. Carlquist, Molecular basis of agonism and antagonism in the oestrogen receptor, Nature 389 (1977), 753-758.
2. R.G. Ziegler, R.N. Hoover, M.C. Pike et al., Migration patterns and breast cancer risk in Asian-American women, J. Nat. Cancer Inst. 85 (1993), 1819-1827.
3. W. Zheng, Q. Dai, L. Custer, X.O. Shu, W.Q. Wen, F. Jin and A.A. Franke, Urinary excretion of isoflavonoids and the risk of breast cancer, Cancer Epidemiol. Biomark. Prev. 8 (1999), 35-40.
4. P.M. Martin, K.B. Horwitz, D.S. Ryan and W.L. McGuire, Phytoestrogen interaction with estrogen receptors in human breast cancer cells, Endocrinology 103 (1978), 1860-1867.
5. Z. Djuric, G. Chen, D.R. Doerge, L.K. Heilbrun and O. Kucuk, Effect of soy isoflavone supplementation on markers of oxidative stress in men and women, Cancer Letters 172 (2001), 1-6.
6. 2M phase of the cell cycle, J. Cell. Biochem. 79 (2000), 594-600.
7. S. Balabhadrapathruni, T.J. Thomas, E.J. Yurkow, P.S. Amenta and T. Thomas, Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-468 human breast cancer cell, Oncol. Rep. 7 (2000), 3-12.
8. Y.J. Surh, J.Y. Lee, K.J. Choi and S.R. Ko, Effects of selected ginsenosides on phorbol-ester-induced expression of cyclooxygenase-2 and activation of NF-kappa B and ERK1/2 in mouse skin, Ann N.Y. Acad. Sci. 973 (2002), 396-401.
9. I. Nenci, E. Marchetti and P. Querzoli, Commentary on human mammary preneoplasia. The estrogen receptor-promotion hypothesis, J. Steriod Biochem. 30 (1988), 105-106.
10. B. Perillo, A. Sasso, C. Abbondanza and G. Palumbo, 17 beta-estradiol inhibits apoptosis in MCF-7 cells, including bcl-2 expression via two estrogen-responsive elements present in the coding sequence, Mol. Cell. Biol. 20 (2000), 2890-2901.
11. M.N. Zoubine, A.P. Weston, D.C. Johnson, D.R. Campbell and S.K. Banerjee, 2-Methoxyestradiol-induced growth suppression and lethality in estrogen-responsive MCF-7 cells may be mediated by down regulation of p34cdc2 and cyclin B1 expression, Int. J Oncol. 4 (1999), 639-646.